Key Drivers
- Strong Liquidity
- Margin Recovery
- Ongoing Cash Burn
AIAI Summary
OPK now looks like an asset-backed turnaround rather than a pure cash-burn story, with EBITDA turning positive and non-dilutive royalty financing easing near-term pressure, but the stock still hinges on whether restructuring gains can translate into durable cash generation before persistent free-cash-flow burn and early-stage pipeline risk reassert themselves.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Margin Recovery
- •Ongoing Cash Burn
OPK has solid liquidity and a sharply improved latest quarter, but persistent losses, negative free cash flow, and heavy intangible assets keep the outlook cautious.
Price Behavior
Key Price Behavior Insights:
- •Support Hold
- •Failed Breakout
- •Range Bound
OPK's last month showed a constructive but range-bound pattern, with buyers defending $1.31-$1.32 and the stock holding above $1.22-$1.24, while repeated failure to extend above $1.40-$1.46 after the $1.65 spike keeps breakout risk unconfirmed.
Sharp spike to $1.65 on 2026-07-28 quickly reversed, showing volatile failed breakout behavior
Sentiment & News
Key News Insights:
- •Earnings Beat
- •Raised Guidance
- •Royalty Financing
OPKO Health posted a stronger quarter with a narrower loss, revenue beat, raised 2026 guidance, and added non-dilutive financing, while pipeline updates support the longer-term story.
The news is positive for OPKO Health, improving near-term sentiment and financial flexibility while keeping pipeline execution as the main watch point
Similar Companies in Healthcare
Other companies in the same sector with AI ratings